We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

38 hedge funds and large institutions have $15.3M invested in Albireo Pharma Inc in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 17 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% less funds holding

Funds holding: 46 → 38 (-8)

61% less capital invested

Capital invested by funds: $39.1M → $15.3M (-$23.8M)

65% less call options, than puts

Call options by funds: $7K | Put options by funds: $20K

71% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 17

80% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 10

Holders
38
Holders Change
-8
Holders Change %
-17.39%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
17
Closed
10
Calls
$7K
Puts
$20K
Net Calls
-$13K
Net Calls Change
+$17K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$301K
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$196K
3
PSUF
People's United Financial
Connecticut
+$16.8K
4
BIT
BlackRock Institutional Trust
California
+$13.4K
5
VKH
Virtu KCG Holdings
New York
+$9.27K

Top Sellers

Rank Fund Capital Flow
1
AIC
AWM Investment Company
New York
-$848K
2
OPPM
Opus Point Partners Management
New York
-$670K
3
GPP
Great Point Partners
Connecticut
-$583K
4
BC
Broadfin Capital
New York
-$356K
5
ACP
Acuta Capital Partners
California
-$284K
Name Holding Trade Value Shares
Change 		Change in
Stake
FAAS
26
First Allied Advisory Services
California
$9K – – –
PSUF
27
People's United Financial
Connecticut
$9K +$16.8K +667 New
Ameriprise
28
Ameriprise
Minnesota
$7K -$1.69K -67 -12%
FMA
29
FNY Managed Accounts
New York
$4.4K -$16.8K -667 -67%
BIM
30
BlackRock Investment Management
Delaware
$4K – – –
Citadel Advisors
31
Citadel Advisors
Florida
$2K -$2.62K -104 -45%
PMFA
32
Plante Moran Financial Advisors
Michigan
$1K – – –
OPPM
33
Opus Point Partners Management
New York
– -$670K -21,667 Closed
SCM
34
Sio Capital Management
New York
– -$165K -5,351 Closed
Dimensional Fund Advisors
35
Dimensional Fund Advisors
Texas
– -$57K -1,846 Closed
Nomura Holdings
36
Nomura Holdings
Japan
– -$28K -900 Closed
ARTA
37
A.R.T. Advisors
New York
– -$18K -610 Closed
RCM
38
Rotella Capital Management
Washington
– -$19K -607 Closed
Bank of New York Mellon
39
Bank of New York Mellon
New York
– -$15K -479 Closed
UBS Group
40
UBS Group
Switzerland
– -$10.5K -416 -97%
Wells Fargo
41
Wells Fargo
California
– -$5K -167 Closed
Morgan Stanley
42
Morgan Stanley
New York
– -$76 -3 -30%
Creative Planning
43
Creative Planning
Kansas
– +$126 +5 New
1
2

ALBO Hedge Fund Activity: Q3 2015 in Review

38 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q3 2015, worth a combined $15.3M — down 61% from $39.1M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of ALBO and 2 opened new positions — a net loss of 8 holders — while 17 trimmed existing stakes and 5 added.

The largest buyer was Vanguard Group, adding an estimated $301K. The largest seller was AWM Investment Company, cutting an estimated $848K.

  • 38 institutional investors held Albireo Pharma Inc (ALBO) as of Q3 2015, down from 46 in Q2 2015.
  • Funds reported $15.3M of Albireo Pharma Inc stock for Q3 2015, down 61% quarter-over-quarter.
  • 2 funds opened new Albireo Pharma Inc positions in Q3 2015 and 10 closed out, a net change of -8 holders.
  • The largest Albireo Pharma Inc buyer in Q3 2015 was Vanguard Group, an estimated $301K added.
  • The largest Albireo Pharma Inc seller in Q3 2015 was AWM Investment Company, an estimated $848K sold.

Based on aggregated 13F filings for Q3 2015.